Thus, illumination of the significance of IL-13Rα2 expression in gastric cancer might provide some additional prognostic information other than the TNM staging system for a further risk stratification and provide guidance for a more precise treatment for gastric cancer patients. The gene discussed is IL13RA2; the disease is gastric cancer.